Geraldine
Geraldine Bechamp, Scottsdale, AZ US
Patent application number | Description | Published |
---|---|---|
20100229916 | PROTECTION SYSTEM - An assembly, solar panel, and solar panel protection system have a deployable and retractable flexible resilient mesh barrier which can be extended to cover and protect a surface which is vulnerable to hail and other airborne projectiles. The mesh barrier can be attached to a frame so as to occupy a plane over the surface. The mesh can be held on a powered or unpowered reel and extended on demand. The reel can have an automatically acting controller which extends the mesh responsive to a remote signal such as a warning signal from a weather announcing authority. The mesh barrier can incorporate a heating element to remove accumulated ice. | 09-16-2010 |
Geraldine Bous, Sophia-Antipolis Cedex FR
Patent application number | Description | Published |
---|---|---|
20150113451 | CREATION OF WIDGETS BASED ON A CURRENT DATA CONTEXT - Creation of a widget for presenting a key indicator is initiated based on a selection over first displayed data. The selection is made over a portion of the first displayed data. A current data context for the first displayed data and the made selection is determined. Based on the current data context, a list of widget types available for creation of a widget for the key indicator is suggested. For the elements from the list of widget types, an advice is built to include a list of widget descriptors. An interaction is made to select a widget descriptor from the advice. According to the selected widget descriptor, a widget is created that embeds a query that extracts a portion of the current data context in order to present relevant widget data for the key indicator within the widget. | 04-23-2015 |
Geraldine Brown, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20080228524 | Method of manipulating health related documents - A method is disclosed for submitting, collecting, storing and retrieving (1) advanced directives such as living wills, medical proxies, (2) medical and pharmaceutical records, and (3) wills and estate documents, all within a secure environment. Once individual consumers have registered and provided appropriate identifying information for use in retrieving stored documents later, they enter a secure area of the website and may use the forms of advanced directives and testamentary documents provided there, may choose to follow displayed hypertext links that lead to forms mandated by the jurisdiction where they are resident (if available), or may choose to submit their own forms prepared in coordination with their personal legal, healthcare and tax advisors. The documents are stored in electronic format in a remote location and may only be retrieved online at a later date by an individual or a healthcare provider possessing the credentials required to access the online vault. | 09-18-2008 |
Geraldine Carlos, Neuilly Sur Seine FR
Patent application number | Description | Published |
---|---|---|
20120150335 | Performance Monitoring Of Advanced Process Control Systems - Techniques are described for monitoring the performance of advanced process control (APC) systems used to control complex industrial processes. By correlating an alarm status of the APC system with an alarm status associated with the service factor (or service factor thresholds), a plant operator can understand how well the APC system performs over time, as well as identify when operator intervention may be required (or alternatively, may be the source of poor plant performance). Accordingly, embodiments of the invention can significantly impact both the reliability and efficiency of complex industrial process, e.g., the production of industrial gases using air separation units (ASUs) and steam methane reformer (SMR) furnaces. | 06-14-2012 |
Geraldine Civil, Nepean CA
Patent application number | Description | Published |
---|---|---|
20080281987 | FACILITATING AUTOMATIC PROTECTION SWITCHING FOR PROVIDER BACKBONE NETWORK - An existing protection mechanism is enhanced through the use of an automatic protection switching protocol data unit (APS PDU). In conjunction with transmitting Ethernet frames to a second bridge over a primary path, a first bridge transmits APS PDUs to the second bridge over a secondary path. The APS PDUs provide the second bridge with information about the protection switching mechanism being used and provide indications regarding the status of the primary path. In particular, protection switching may be facilitated by forming an APS PDU that is extended to include an indication of an identity for a trunk or a primary path before transmitting the APS PDU to the second bridge. Alternatively, after forming a regular APS PDU, protection switching may be facilitated by encapsulating the regular APS PDU with information identifying a trunk or a primary path before transmitting the APS PDU to the second bridge. | 11-13-2008 |
Geraldine Deliencourt-Godefroy, Bois D'Ennebourg FR
Patent application number | Description | Published |
---|---|---|
20130171180 | DERIVATIVES OF GLYCO-CF2-SERINE AND GLYCO-CF2-THREONINE - The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, as well as to their process of preparation, their use in the peptide synthesis, said peptide and the use of said peptide. | 07-04-2013 |
20140105839 | FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS - The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLT1, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti-inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin. | 04-17-2014 |
20140199727 | GEM-DIFLUORINATED C-ISOPROPYLGALACTOSIDE DERIVATES - The present invention concerns compounds of the following formula (I) or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in which R represents H, OH or OR | 07-17-2014 |
Geraldine Duisit, Paris FR
Patent application number | Description | Published |
---|---|---|
20100043494 | PROCESS FOR FABRICATING A MICROFLUIDIC DEVICE - The invention relates to a method of fabricating “open” microfluidic devices by screen printing. The method comprises steps consisting in: | 02-25-2010 |
Geraldine Ferron-Brady, Upper Providence, PA US
Patent application number | Description | Published |
---|---|---|
20160067307 | METHODS OF TREATING CANCER - Methods of treating cancers comprising FGFR1 gene amplification, FGFR1 overexpression, FGFR3 overexpression, FGFR3 amplification, FGF2 overexpression, and/or FGF2 gene amplification are provided. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule. In some embodiments, the methods comprise administering a FGFR1 ECD and/or an FGFR1 ECD fusion molecule in combination with at least one additional therapeutic agent. In some embodiments, methods of treating cancers comprising administering a FGFR1 ECD and/or an FGFR1 ECD fusion molecule in combination with at least one chemotherapeutic agent are provided. | 03-10-2016 |
Geraldine Goebrecht, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20150030619 | Activation and Expansion of T Cell Subsets Using Biocompatible Solid Substrates with Tunable Rigidity - The present invention provides compositions and methods for activation and expansion of T cells using a biocompatible solid substrate with tunable rigidity. Rigidity of a substrate is an important parameter that can be used to control the overall expansion and differentiation of T cells. | 01-29-2015 |
Geraldine Gouhier, Criquetot Sur Ouville FR
Patent application number | Description | Published |
---|---|---|
20110243857 | SMART CONTRAST AGENTS FOR MRI IMAGING - A contrast agent for MRI imaging includes: (a) one cyclodextrin, whose truncated-cone-shaped structure defines a central axis, a first and a second openings along the axis, (b) one paramagnetic element, located on the cyclodextrin axis, outside the structure and proximate to the first opening, (c) one or several coordination ligand(s) of the paramagnetic element which coordinate(s) the paramagnetic element, (d) one arm covalently bound to the cyclodextrin, proximate to the second opening, which is able to form an inclusion complex with the cyclodextrin. | 10-06-2011 |
Geraldine Grouard-Vogel, Paris FR
Patent application number | Description | Published |
---|---|---|
20130259892 | STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF - An immunogenic product includes TNFα coupled with KLH, wherein the TNFα is strongly inactivated, which means that the product shows less than 30% of cytolytic activity and/or an inactivation factor of more than 15000, in the conditions of TEST A. An emulsion and a vaccine including the product and methods for preparing the immunogenic product are also described. | 10-03-2013 |
20140023617 | METHOD FOR TREATING IFNALPHA RELATED CONDITIONS - An immunogenic product including IFNα coupled to a carrier protein molecule is capable to induce in vivo anti-IFNα antibodies and is useful in treating IFNα related conditions. | 01-23-2014 |
Geraldine Horigan, Northern Ireland GB
Patent application number | Description | Published |
---|---|---|
20100324019 | Use of Riboflavin in the Treatment of Hypertension - The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism, comprising a pharmaceutically effective amount of an anti-hypertensive agent and riboflavin, and the invention further provides a method of treatment of such a subject comprising the administration of riboflavin. | 12-23-2010 |
Geraldine Kok-Jacon, Hamme-Mille BE
Patent application number | Description | Published |
---|---|---|
20090300798 | Transformed Plant Expressing a Mutansucrase and Synthesizing a Modified Starch - The present invention relates to plant cells and plants, which are genetically modified, wherein the genetic modification leads to the expression in plastids of such plant cells and plants of an enzyme having the activity of a mutansucrase. Furthermore, the present invention relates to means and methods for the manufacture of such plant cells and plants. Plant cells and plants of this type synthesise a modified starch. The present invention therefore also relates to the starch synthesised by the plant cells and plants according to the invention as well as to methods for the manufacture of the starch and to the manufacture of starch derivatives of this modified starch. | 12-03-2009 |
Geraldine Kok-Jacon, Ambresin BE
Patent application number | Description | Published |
---|---|---|
20090064372 | Transformed Plant Expressing a Dextransucrase and Synthesizing a Modified Starch - The present invention relates to plant cells and plants, which are genetically modified, wherein the genetic modification leads to the expression in plastids of such plant cells and plants of an enzyme having the activity of a dextransucrase. Furthermore, the present invention relates to means and methods for the manufacture of such plant cells and plants. Plant cells and plants of this type synthesis a modified starch. The present invention therefore also relates to the starch synthesized by the plant cells and plants according to the invention as well as to methods for the manufacture of the starch and to the manufacture of starch derivatives of this modified starch. | 03-05-2009 |
Geraldine Lerebour, Les Loges En Josas FR
Patent application number | Description | Published |
---|---|---|
20120263768 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR - The present invention relates to a fluid composition intended for protecting the skin and/or hair against ultraviolet radiation, characterized by the fact that it comprises, in a cosmetically acceptable aqueous support, at least: (a) one photoprotective system capable of screening out UV radiation; and (b) one 2-alkoxy-4-alkyl ketone phenol compound. The present invention also relates to the use of a 2-alkoxy-4-alkyl ketone phenol compound in a composition comprising, in a cosmetically acceptable medium, at least one photoprotective system capable of screening out UV radiation. | 10-18-2012 |
20120269739 | COMPOSITION, USE, AND PRESERVATION METHOD - The invention relates to a cosmetic, pharmaceutical, dermatological, nutraceutical or oral cosmetic composition having, as main preserving system, a mild preserving system formed from compounds with a broad antimicrobial spectrum, which have only one pKa, the said pKa being greater than or equal to 10, the said mild preserving system being present in a content strictly greater than or equal to 1% by weight relative to the weight of the said composition. | 10-25-2012 |
20150064225 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR - The present invention relates to a fluid composition intended for protecting the skin and/or hair against ultraviolet radiation, characterized by the fact that it comprises, in a cosmetically acceptable aqueous support, at least: (a) one photoprotective system capable of screening out UV radiation; and (b) one 2-alkoxy-4-alkyl ketone phenol compound. The present invention also relates to the use of a 2-alkoxy-4-alkyl ketone phenol compound in a composition comprising, in a cosmetically acceptable medium, at least one photoprotective system capable of screening out UV radiation. | 03-05-2015 |
Geraldine Lievre, Tournon-Sur-Rhone FR
Patent application number | Description | Published |
---|---|---|
20140201066 | SYSTEM AND METHOD FOR ENABLING TRANSACTIONS ON AN ASSOCIATED NETWORK - A method and system are disclosed for wireless payment and information collection. A central system generates a personalized application including unique application and transaction identifiers, security keys, and signatures for a user device. The user device implements the personalized application in order to access the services of the associated network. Tags, capable of short-range communication with the user devices, are deployed to service access points of the associated network. The tags and user device mutually authenticate and share identifiers. Validation of the user device results in the tag updating an irreversible counter, generating transaction certificate, and logging this transaction information. The transaction certificate and a portion of the log are communicated to the user device, and service is granted. The user device transmits the transaction information and log to the central system for billing when a network connection is available. | 07-17-2014 |
Geraldine Louf, Cachan FR
Patent application number | Description | Published |
---|---|---|
20090317854 | Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase - Diagnostic testing and immunomonitoring that uses genetically detoxified | 12-24-2009 |
Geraldine Maclear, Burnaby CA
Patent application number | Description | Published |
---|---|---|
20100226487 | METHOD & APPARATUS FOR CONTROLLING THE STATE OF A COMMUNICATION SYSTEM - A networked conferencing device includes at least one speaker, a display and a plurality of environmental sensors such as cameras, microphones, light level sensors, thermal sensors and motion sensors. The conferencing device receives environmental information from the sensors and processes this information to identify qualified events. The identified qualified events are then used to determine a next powered state for the conferencing device. If the next powered state is different than a current powered state, then the conferencing system transitions to the next powered state. | 09-09-2010 |
Geraldine Manette, Athis-Mons FR
Patent application number | Description | Published |
---|---|---|
20140194470 | DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF - The invention relates to compounds corresponding to formula (I), in the form of the base or of an acid-addition salt: | 07-10-2014 |
Geraldine Marcenyac, Norwalk, CT US
Patent application number | Description | Published |
---|---|---|
20080262284 | DISPOSAL SYSTEM FOR TRANSDERMAL DOSAGE FORM - The present invention relates to a disposable article to prevent the misuse of a transdermal dosage form (FIG. | 10-23-2008 |
20150182474 | DISPOSAL SYSTEM FOR TRANSDERMAL DOSAGE FORM - The present invention relates to a disposable article to prevent the misuse of a transdermal dosage form (FIG. | 07-02-2015 |
Geraldine Marshall, Stone Mountain, GA US
Patent application number | Description | Published |
---|---|---|
20140130247 | FULL BODY BATH MAT - Implementations of a full body mat are provided. In some implementations, the full body mat comprises a plurality of circular-shaped cushions, wherein each of the plurality of circular-shaped cushions has one or more suction cups on the back to secure the cushion to a surface. Each of the plurality of circular-shaped cushions can be =sized based on the location of the cushion. Furthermore, each of the plurality of circular-shaped cushions is filed with a material to provide support. | 05-15-2014 |
Geraldine Martin, La Tour Du Pin FR
Patent application number | Description | Published |
---|---|---|
20080254248 | Bonding Intermediate for Silicone Coated Textile - Bonding intermediate between two textiles each having a coating layer of silicone-based polymer, the said intermediate comprising a composition based on a non-crosslinked silicone elastomer, and a release film positioned on a first side of the said intermediate, characterized in that it has the shape of a planar rectilinear section of a strip based on the said non-crosslinked silicone elastomer, and in that it comprises a translucent film provided on the second side of the strip. | 10-16-2008 |
Geraldine Mlynarz Zylberberg, Santiago CL
Patent application number | Description | Published |
---|---|---|
20130172284 | USE OF 1-BETA-D-RIBOFURANOSYL-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE FOR THE TREATMENT OF INFECTIOUS SALMON ANEMIA - The invention relates to the novel use of 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anaemia caused by the infectious salmon anaemia or ISA virus in salmonids. | 07-04-2013 |
20130190263 | ORAL VETERINARIAN COMPOSITION FOR SALMONIDS COMPRISING 1-BETA-D-RIBOFURANOSYL-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE AND USE THEREOF IN THE TREATMENT OF INFECTIOUS ANEMIA IN SALMONIDS - The invention relates to a novel oral veterinary composition for salmonids, comprising 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide and to the use thereof for the treatment of infectious salmon anaemia (USA) caused by the infectious salmon anaemia or ISA virus in salmonids. | 07-25-2013 |
Geraldine Porcu, Septemes-Les-Vallons FR
Patent application number | Description | Published |
---|---|---|
20100112605 | Biomarker for the Medicine and the Biology of the Reproduction - The present invention relates to a new biomarker for the medicine and the biology of reproduction, in particular for in vitro fertilization (IVF) outcome. It relates to methods for predicting IVF outcome and for selecting the subject for IVF. | 05-06-2010 |
Geraldine Primazot, Compiegne FR
Patent application number | Description | Published |
---|---|---|
20100137633 | Process For Deacetalisation Of Alpha Aminoacetals - The invention relates to a process for the preparation of N-protected α-aminoaldehydes by deacetalization of the acetal functional group of corresponding N-protected α-aminoacetals using formic acid. | 06-03-2010 |
20100152490 | Process Of Racemisation Of Optically Active Alpha Aminoacetals - The invention relates to a process for preparing α-aminoacetals substantially in racemic form, comprising a step of oxidizing optically enriched α-aminoacetals to the corresponding oximes, in the presence of a catalyst, and a step of reducing the oximes thus obtained. | 06-17-2010 |
20110034726 | Process Of Preparation Of Optically Active Alpha Aminoacetals - The invention relates to a process for preparing optically active α-aminoacetals by resolution of a racemic mixture or of a mixture of enantiomers via the formation of diastereoisomeric salts, and also novel intermediates in the form of diastereoisomeric salts. | 02-10-2011 |
Geraldine Rames-Langlade, Viroflay FR
Patent application number | Description | Published |
---|---|---|
20130269785 | INDIRECT-INJECTION METHOD FOR MANAGING THE SUPPLY OF CRYOGENIC LIQUID TO A TRUCK FOR TRANSPORTING HEAT-SENSITIVE PRODUCTS - The invention relates to a method for managing the supply of cryogenic liquid to a truck for transporting heat-sensitive materials, said truck implementing a method using said cryogenic liquid to transfer negative calories to the materials. Said method is a so-called indirect-injection method in which the liquid is fed into a heat-exchanger system located inside the truck, where said liquid evaporates. The transfer of cold to the materials is achieved by means of an exchange between the atmosphere surrounding the materials and the cold walls of the heat-exchanger system, characterized in that the heat-exchanger system is supplied with cryogenic liquid by implementing the following measures: an upstream two-position valve, generally closed, is placed upstream from the heat-exchanger system; a proportional analog valve, generally open, is placed downstream from the heat-exchanger system; and a downstream two-position valve, generally open, is placed downstream from the analog valve. | 10-17-2013 |
Geraldine San Jose, Mios FR
Patent application number | Description | Published |
---|---|---|
20140378418 | COMPOUNDS FOR INHIBITING 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE - In particular, the compound is effective to inhibit Dxr in | 12-25-2014 |
Geraldine Taylor, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20100068226 | Polynucleotides and Uses Thereof - The present invention provides an isolated polynucleotide comprising or consisting of the nucleotide sequence encoding the G protein of human respiratory syncytial virus (RSV), wherein the nucleotide sequence is codon optimised for expression in mammalian cells and wherein the polynucleotide provides increased expression of the G protein in mammalian cells relative to expression of the wildtype RSV-G gene. Preferably, the polynucleotide comprises or consists of the nucleotide sequence of SEQ ID NO:2. Further aspects of the invention provide pharmaceutical compositions, in particular vaccines, for use in methods of immunising a subject against RSV infection. | 03-18-2010 |
Geraldine Tortelier, Herndon, VA US
Patent application number | Description | Published |
---|---|---|
20110167342 | CHILD-SAFE MEDIA INTERACTION - A safe-media interaction system includes distinct child and parent interfaces through which a child can interact with content and applications that are selected and authorized by a parent through the parent interface. The child interface allows a young child who has not yet acquired any reading skills, verbal skills, or visual organization skills to select a content item or application feature from a selection of such items/features visually presented to the child and interact with the selected item/feature through a general purpose computer interface such as a touch screen or keyboard with labels placed over selected keys. The safe-media interaction system also supports special purpose interfaces such as remote controls, kid-safe toys, and a dance pad to facilitate early childhood use of the system. | 07-07-2011 |
Geraldine Tosin, Etterbeek BE
Patent application number | Description | Published |
---|---|---|
20120022224 | Particles Including Zeolite Catalysts And Their Use In Oligomerization Processes - Embodiments of an invention disclosed herein relate to particles made from zeolite catalysts and their use in oligomerization processes. In particular, shaped particles (for example, spheroid particles) are made from compositions including the contact product of at least one zeolite catalyst and at least one binder. | 01-26-2012 |
20140148625 | Processes Utilizing Solvent Extraction - Embodiments of an invention disclosed herein relate to processes utilizing solvent extraction to remove nitrogen containing compounds and optionally other components from feedstreams of olefins and paraffins. | 05-29-2014 |
Geraldine Tosin, Notre Dame De Gravenchon FR
Patent application number | Description | Published |
---|---|---|
20140330060 | Integrated Nitrile Poison Adsorption and Desorption System - In a feed clean-up process at least two adsorbents ( | 11-06-2014 |
20150038753 | Olefin Oligomerization Process - The invention provides an olefin oligomerization process comprising the steps of: i) reducing the level of nitriles in an olefin feed by contacting the feed with a guard bed comprising gamma alumina having a surface area greater than 250 m | 02-05-2015 |
20150158786 | Olefin Oligomerization Process - The invention relates to an olefin oligomerization process comprising the steps of: i) contacting a feed comprising olefins and nitriles with a guard bed comprising eta alumina; and ii) contacting the feed obtained in step i) with an oligomerization catalyst under conditions suitable to oligomerize the olefins in the feed. It also relates to the use of a guard bed comprising eta-alumina for reducing the content of basic organic compounds in a hydrocarbon feed. | 06-11-2015 |
Geraldine Tosin, Woluwe-Saint-Lambert BE
Patent application number | Description | Published |
---|---|---|
20140221716 | Olefin Oligomerization Process - The present invention provides an olefin oligomerization process comprising the steps of: i) reducing the level of acetonitrile in an olefin feed by contacting the feed with a non-zeolitic metal oxide; and ii) contacting the olefin feed with reduced level of acetonitrile with an olefin oligomerization catalyst under conditions suitable to oligomerize the olefin. | 08-07-2014 |
20140256892 | Olefin Olegomerization Process - An olefin oligomerization process comprises contacting an olefin feed with a catalyst composition. The catalyst composition includes a crystalline aluminosilicate having FAU, EMT or a combination of FAU and EMT framework type. The crystalline aluminosilicate has cobalt and at least one alkaline earth metal selected from calcium, barium, strontium and mixtures thereof within its intra-crystalline cages. | 09-11-2014 |
Geraldine Venthoye, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20140206638 | PULMONARY DELIVERY OF AMINOGLYCOSIDE - The present invention is directed to the administration of aminoglycosides. In particular, the present invention is directed to compositions and methods for the pulmonary administration of aminoglycosides. According to a preferred embodiment, compositions and methods are provided for the localized treatment of respiratory infections. | 07-24-2014 |
Geraldine Vermac, Springbrook Township, PA US
Patent application number | Description | Published |
---|---|---|
20080214089 | Get well toy - The present invention relates to a toy being a doll or stuffed animal for aiding a child with a medical disorder. The toy has internal circuitry allowing it to store and play back comments, some of which are designed to remind the child of medical treatments and familiarize the child with the nature of the treatments. It is also programmed to play back comments which put the child at ease. These comments may be scheduled at specific times, or output at random times. There may also be sound, light and motion sensors in addition to an internal clock which determine the current conditions. Certain comments are output on certain conditions as measured by the sensors. In addition, the toy may monitor the child to determine periods of crying and sleep cycles for later download to a medical professional. | 09-04-2008 |
Geraldine Vourch, Montigny Le Bretonneux FR
Patent application number | Description | Published |
---|---|---|
20090198428 | METHOD FOR ADAPTING EMERGENCY BRAKING DETECTION TO SEQUENCED BRAKING RECOGNITION - A method for controlling braking in a motor vehicle equipped with a brake servo unit capable of being implemented in a braking system including: a hydraulic master cylinder associated with a vacuum brake booster and with hydraulic circuits supplying the wheel brakes equipping the vehicle wheels; an ABS hydraulic unit with wheel antiskid function, and an electronic mechanism implementing emergency braking assisted by the hydraulic unit. The method detects serial repetition in time for implementing emergency braking operations and adapts the conditions for implementing an emergency braking in case of serial repetition. | 08-06-2009 |
Géraldine Agusti, Villeurbanne FR
Patent application number | Description | Published |
---|---|---|
20130108574 | RADIOPAQUE, NON-BIODEGRADABLE, WATER-INSOLUBLE IODINATED BENZYL ETHERS OF POLY(VINYL ALCOHOL), PREPARATION METHOD THEREOF, INJECTABLE EMBOLIZING COMPOSITIONS CONTAINING THEREOF AND USE THEREOF | 05-02-2013 |
20150335779 | Method of Embolization using a Radiopaque, Non-Biodegradable, Water-Insoluble Iodinated Benzyl Ether of PolyI(Vinyl Alcohol) - A method of embolizing an area of treatment includes providing a composition that includes a radiopaque, non-biodegradable, water-insoluble iodinated benzyl ether of poly(vinyl alcohol) consisting of a poly(vinyl alcohol) (PVA) having covalently grafted thereon iodinated benzyl groups comprising from 1 to 4 iodine atoms per benzyl group as the only substituents wherein a grafted repeating unit has formula (I) | 11-26-2015 |
Géraldine Arrode-Bruses, Meylan FR
Patent application number | Description | Published |
---|---|---|
20140370051 | CHIMERIC NON-INTEGRATING LENTIVIRAL GENOMES AS VACCINES AGAINST HIV-1 - Novel nucleic acids include non-integrative chimeric retroviral genomes including the 5′ and 3′ long terminal repeat sequences (LTRs) of the caprine lentivirus: the Caprine Arthritis Encephalitis Virus (CAEV) or of another retrovirus not integrating human cells and at least one viral gene of another retrovirus. A vector including such a nucleic acid, an immunogenic or vaccinal composition including the vector or the nucleic acid, as well as their use for treating and/or preventing an infection by a retrovirus or a disease induced by a pathogenic agent are also described. | 12-18-2014 |
Géraldine Artaud, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20110206090 | Method for Optimizing an Acquisition of a Spread-Spectrum Signal from a Satellite by a Mobile Receiver - A method for optimizing the acquisition phase of a spread-spectrum signal by a mobile receiver includes searching for the path having the maximum energy for different frequency assumptions and among all the positive trend paths of said frequencies between two initial and final instants marking the beginning and the end of a coherent signal integration. | 08-25-2011 |
Géraldine Cancel-Tassin, Soisy-Sur-Seine FR
Patent application number | Description | Published |
---|---|---|
20110301863 | PREDICTION METHOD FOR THE SCREENING, PROGNOSIS, DIAGNOSIS OR THERAPEUTIC RESPONSE OF PROSTATE CANCER, AND DEVICE FOR IMPLEMENTING SAID METHOD - The invention includes a prediction method for the screening or diagnosis or therapeutic management or prognosis of prostate cancer, including collecting individual input data and providing predictive information on the risk linked to a type of disease. The input data includes at least one variable or a combination of variables of the genetic type such as the identification of markers of genetic polymorphisms considered as being linked to the development of the disease. The invention also provides an individual prediction device for the screening or diagnosis or therapeutic management or prognosis of prostate cancer including first means for acquiring individual information data by a user, and at least a first software interface on which the said first means operate. The invention additionally includes a computer program product having the method and providing predictive information on risk linked to a disease. | 12-08-2011 |
Géraldine Castelot-Deliencourt-Godefroy, Rouen FR
Patent application number | Description | Published |
---|---|---|
20090311203 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS - The invention relates to a gem-difluoride C-glycopeptide compound with formula I where n is an integer equal to 3 or 4, R represents a hydrogen atom, an alkyl, benzyl, acetyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl group, R′ represents OR, NR′R″, N | 12-17-2009 |
20090318678 | Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs - The invention concerns a C-glycoside compound of formula (I); wherein: n is equal to 1 or 2; Y represents H or halogen; X is an alkyl chain bearing at least one amino, amide, acid, ester, carbonyl, alcohol, aryl function or a carbonyl, ester amide, amino, alcohol group; the R's, identical or different, represent a OH or OR′ group where R′ is an alkyl, benzyl, benzoyl, acetyl, pivaloyl, trialkylsilyl, tertiobutyldiphenylsilyl group or one or more sugars; R1 represents OR′, NR″R″′, N3, or a phthalamide with R″ and R″′, identical or different, represent H or an alkyl, aryl, benzyl, benzoyl, acetyl, alkoxycarbonyl, allyloxycarbonyl, benzyloxycarbonyl group; R2 represents H or halogen or a OH, OR, NR″R″′ or N3 group, as well as derivatives thereof in physiologically or pharmaceutically acceptable base, mineral or organic acid-addition salt, hydrate or solvate form. The invention is useful for preparing C-glycoside compounds or C-glycoconjugates applicable in particular in cosmetology, medical imagery, immunology for treating cancer, diabetes, hypertension. | 12-24-2009 |
20100041584 | GEM DIFLUORINATED C-GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE FOR THE PRESERVATION OF BIOLOGICAL MATERIALS AND/OR IN CRYOSUGERY - The invention concerns a gem-difluorinated C-glycopeptide compound of formula (I) in which N is an integer between 1 and 5, R | 02-18-2010 |
20110034402 | C-ARYL GLYCOSIDE COMPOUNDS FOR THE TREATMENT OF DIABETES AND OBESITY - This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in particular for use thereof as a drug, notably in the treatment of diabetes. | 02-10-2011 |
Géraldine Castelot-Deliencourt-Godefroy, Rouen FR
Patent application number | Description | Published |
---|---|---|
20090311203 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS - The invention relates to a gem-difluoride C-glycopeptide compound with formula I where n is an integer equal to 3 or 4, R represents a hydrogen atom, an alkyl, benzyl, acetyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl group, R′ represents OR, NR′R″, N | 12-17-2009 |
20090318678 | Stable C-Glycoside Sugar and C-Glycoconjugate Mimetics, Method for preparing same and uses Thereof in Particular in Cosmetics and Drugs - The invention concerns a C-glycoside compound of formula (I); wherein: n is equal to 1 or 2; Y represents H or halogen; X is an alkyl chain bearing at least one amino, amide, acid, ester, carbonyl, alcohol, aryl function or a carbonyl, ester amide, amino, alcohol group; the R's, identical or different, represent a OH or OR′ group where R′ is an alkyl, benzyl, benzoyl, acetyl, pivaloyl, trialkylsilyl, tertiobutyldiphenylsilyl group or one or more sugars; R1 represents OR′, NR″R″′, N3, or a phthalamide with R″ and R″′, identical or different, represent H or an alkyl, aryl, benzyl, benzoyl, acetyl, alkoxycarbonyl, allyloxycarbonyl, benzyloxycarbonyl group; R2 represents H or halogen or a OH, OR, NR″R″′ or N3 group, as well as derivatives thereof in physiologically or pharmaceutically acceptable base, mineral or organic acid-addition salt, hydrate or solvate form. The invention is useful for preparing C-glycoside compounds or C-glycoconjugates applicable in particular in cosmetology, medical imagery, immunology for treating cancer, diabetes, hypertension. | 12-24-2009 |
20100041584 | GEM DIFLUORINATED C-GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE FOR THE PRESERVATION OF BIOLOGICAL MATERIALS AND/OR IN CRYOSUGERY - The invention concerns a gem-difluorinated C-glycopeptide compound of formula (I) in which N is an integer between 1 and 5, R | 02-18-2010 |
20110034402 | C-ARYL GLYCOSIDE COMPOUNDS FOR THE TREATMENT OF DIABETES AND OBESITY - This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in particular for use thereof as a drug, notably in the treatment of diabetes. | 02-10-2011 |
Géraldine Eudier, Saint Arnoult FR
Patent application number | Description | Published |
---|---|---|
20150107082 | TOOL FOR BANDING MECHANICAL COMPONENTS AND BANDING METHOD USING SUCH A TOOL - A tool for shrink-fitting mechanical parts includes a fixed portion, a movable portion movable relative to the fixed portion, a support for a part to be shrink-fitted, a docking part for docking the tool on a hoop, and an actuator displacing the movable portion when the part to be shrink-fitted is detected in a shrink-fitting position on the hoop receiving the part. In particular, the fixed portion includes a fixed jaw and a housing, and the movable portion includes a movable jaw and a housing. The support and the docking part are disposed in the corresponding housing, respectively, so that the support and the docking part determine sets of parts to be shrink-fitted and/or of hoop parts for the tool. The housings dispose on the tool the docking part and the support with geometric reference to the hoop. | 04-23-2015 |
Géraldine Grouard-Vogel, Paris FR
Patent application number | Description | Published |
---|---|---|
20120148526 | STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF - An immunogenic product includes TNFα coupled with KLH, wherein the TNFα is strongly inactivated, which means that the product shows less than 30% of cytolytic activity and/or an inactivation factor of more than 15000, in the conditions of TEST A. An emulsion and a vaccine including the immunogenic product and methods for preparing the immunogenic product are also described. | 06-14-2012 |
Géraldine Lerebour, Les Loges FR
Patent application number | Description | Published |
---|---|---|
20150080346 | MOISTURIZING COMPOSITION - The present invention relates to a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable medium, at least glyceryl caprylate, 1,3-propanediol and phytic acid or any of the salts thereof, said composition being free from perlite. | 03-19-2015 |
20150086498 | ACHILLEA ESSENTIAL OIL, COSMETIC COMPOSITION COMPRISING IT AND ITS USES - The present invention relates to an | 03-26-2015 |
20150216791 | ESSENTIAL OIL OF SWEET MARJORAM, COMPOSITION COMPRISING IT, COSMETIC TREATMENT METHOD AND USE - The present invention relates to a novel essential oil of sweet marjoram, to the cosmetic or pharmaceutical compositions comprising it, and also to a cosmetic treatment method employing it and to its cosmetic use as anti-dandruff agent. | 08-06-2015 |
20160067173 | COSMETIC USE OF A GERANIOL-RICH ESSENTIAL OIL OF SATUREJA MONTANA AS DEODORANT ACTIVE AGENT - The present invention relates to the cosmetic use, as deodorant active agent, of an essential oil of | 03-10-2016 |
20160095812 | ESSENTIAL OIL OF SATUREJA MONTANA WITH A HIGH GERANIOL CONTENT, AND USE FOR TREATING GREASY SKIN AND/OR THE ASSOCIATED AESTHETIC DEFECTS - The present invention relates to an essential oil of | 04-07-2016 |
Géraldine Manette, Athis-Mons FR
Patent application number | Description | Published |
---|---|---|
20110294788 | DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF AS HIF ACTIVATORS - The present invention relates to novel substituted dihydropyrazolone derivatives, to their preparation and to their therapeutic use as activators of the transcription factor HIF. | 12-01-2011 |
20110301148 | DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF - The invention relates to compounds corresponding to formula (I), in the form of the base or of an acid-addition salt: | 12-08-2011 |
Géraldine Teppaz, Nantes FR
Patent application number | Description | Published |
---|---|---|
20150152188 | AN IL-15 AND IL-15R\alpha SUSHI DOMAIN BASED IMMUNOCYTOKINES - The immunocytokine includes (a) a conjugate, and (b) an antibody or a fragment thereof directly or indirectly linked by covalence to the conjugate, wherein the conjugate includes (i) a polypeptide including the amino acid sequence of the interleukin 15 or derivatives thereof, and a polypeptide including the amino acid sequence. | 06-04-2015 |
Géraldine Van Aubel, Marneffe BE
Patent application number | Description | Published |
---|---|---|
20130302437 | COMPOSITION COMPRISING AN ELICITOR OF THE PLANT IMMUNE SYSTEM - The present invention generally relates to new plant elicitor compositions, and the use of these compositions in agricultural applications, more particularly to protect plants against (infection by) plant pathogens and the corresponding methods of, and uses in, the protection of plants and crops by application of these compositions. | 11-14-2013 |
Géraldine Van Aubel, Marneffe BE
Patent application number | Description | Published |
---|---|---|
20130302437 | COMPOSITION COMPRISING AN ELICITOR OF THE PLANT IMMUNE SYSTEM - The present invention generally relates to new plant elicitor compositions, and the use of these compositions in agricultural applications, more particularly to protect plants against (infection by) plant pathogens and the corresponding methods of, and uses in, the protection of plants and crops by application of these compositions. | 11-14-2013 |
20150045221 | COMPOSITION COMPRISING AN ELICITOR OF THE PLANT IMMUNE SYSTEM - The present invention generally relates to new plant elicitor compositions, and the use of these compositions in agricultural applications, more particularly to protect plants against (infection by) plant pathogens and the corresponding methods of, and uses in, the protection of plants and crops by application of these compositions. | 02-12-2015 |